Abstract
Fas plays a major role in regulating ligand-induced apoptosis in many cell types. It is well known that several cancers demonstrate reduced cell surface levels of Fas and thus escape a potential control system via ligand-induced apoptosis, although underlying mechanisms are unclear. Here we report that the endosome associated trafficking regulator 1 (ENTR1), controls cell surface levels of Fas and Fas-mediated apoptotic signalling. ENTR1 regulates, via binding to the coiled coil domain protein Dysbindin, the delivery of Fas from endosomes to lysosomes thereby controlling termination of Fas signal transduction. We demonstrate that ENTR1 is cleaved during Fas-induced apoptosis in a caspase-dependent manner revealing an unexpected interplay of apoptotic signalling and regulation of endolysosomal trafficking resulting in a positive feedback signalling-loop. Our data provide insights into the molecular mechanism of Fas post-endocytic trafficking and signalling, opening possible explanations on how cancer cells regulate cell surface levels of death receptors.
Highlights
Fas plays a major role in regulating ligand-induced apoptosis in many cell types
We show that endosome associated trafficking regulator 1 (ENTR1) is cleaved during Fas-induced apoptosis revealing a positive feedback loop in apoptotic signalling
Given the tight interaction of ENTR1 with PTPN13 we tested whether depletion of ENTR1 expression levels changes Fas cell surface levels
Summary
It is well known that several cancers demonstrate reduced cell surface levels of Fas and escape a potential control system via ligand-induced apoptosis, underlying mechanisms are unclear. We report that the endosome associated trafficking regulator 1 (ENTR1), controls cell surface levels of Fas and Fas-mediated apoptotic signalling. It has been shown that membrane trafficking of the death receptor plays an important role in Fas apoptotic signalling and that efficient formation of DISC takes place at the level of endosomes and requires the endocytosis of Fas[6]. ENTR1 was originally identified as an antigen in serum derived from colon cancer patients[30] It was identified in a screen for proteins regulating sensitivity to tumour necrosis factor induced apoptosis[31], the underlying mechanism for this remained unclear.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.